← Leaderboards
Jeffrey S King
Virogenomics Biodevelopment, Inc.
$1,416,177
Attributed
$2,563,710
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $998.2K · FY2016–21$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,563,710 · 3
By mechanism
R44$1,995,136 · 1
R43$568,574 · 2
Top collaborators
- Arthur A. Vandenbark2 shared
- Tothu Q Vu1 shared
Others in their field
Top investigators on “Sampling”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Jeffrey P Krischer · University Of South Florida$522,319,685
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- David Heimbrook · Leidos Biomedical Research, Inc.$410,224,927
- Eric S Lander · Whitehead Institute For Biomedical Res$395,613,296
- Richard A Gibbs · Baylor College Of Medicine$356,778,395
Research focus
SamplingPhosphotransferasesCommercializationRecombinant ProteinsSuccessUnited StatesFda ApprovedDoseMonitorProductionResponseSignal TransductionRelapseValidationBlood SpecimenClinical ResearchDesignDiagnosisLaboratoriesMeetingsPharmaceutical PreparationsClinical TrialsAffectClinical Trials Design
Grant awards (4)
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$996,926
R44 · FY2021 · AI · contact PI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects$998,210
R44 · FY2020 · AI · contact PI
Developing novel fibrillin biomarkers for aortic disease$268,643
R43 · FY2019 · HL · contact PI
Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia$299,931
R43 · FY2016 · CA · contact PI